There has been delays due to factors outside his control. They have stuck to the plan and preserved capital. A less steady hand might of rushed around and made other plans and we’d be headed for a capital raise.
These savvy modifications to the phase 1 cholesterol trial will do plenty of the catch up heavy lifting, the delays may end up a blessing. The next few months leading into the phase 1 while the market is scared money looks looks great opportunity to buy some more tickets.
Ann: CEO Remuneration Update, page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
-0.005(3.85%) |
Mkt cap ! $22.77M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 12.0¢ | $38.77K | 309.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 191655 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 14843 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NYR (ASX) Chart |